# Mitsubishi Tanabe Pharma Development America, Inc. – FDA Inspection, Oct 15, 2021

Source: https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/f7044b8b-5d0a-4038-b5b4-93419bd38f76
Source feed: FDA_Inspections

> FDA inspection 1155136 of Mitsubishi Tanabe Pharma Development America, Inc., October 15, 2021. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155136
- Company Name: Mitsubishi Tanabe Pharma Development America, Inc.
- Inspection Date: 2021-10-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1298296 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/dceb2a25-e1ea-4e5b-a250-2f0f9fccf476)
- [FDA Inspection 857641 - 2013-12-04](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/24eb30a9-ccc6-44e7-bcfa-9e1a8da6556c)

Company: https://www.keypedia.com/companies/mitsubishi-tanabe-pharma-development-america-inc/f5e77e46-b625-4cdd-a44a-ecd7583b6baa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
